Rosenstein Ruth E, Fernandez Diego C
Laboratory of Retinal Neurochemistry and Experimental Ophthalmology, Department of Human Biochemistry, School of Medicine/CEFyBO, University of Buenos Aires/CONICET, Buenos Aires, Argentina.
Laboratory of Retinal Neurochemistry and Experimental Ophthalmology, Department of Human Biochemistry, School of Medicine/CEFyBO, University of Buenos Aires/CONICET, Buenos Aires, Argentina ; Present address: Johns Hopkins University, Department of Biology, Baltimore, MD, USA.
Neural Regen Res. 2014 Sep 1;9(17):1581-4. doi: 10.4103/1673-5374.141782.
Diabetic retinopathy is a leading cause of acquired blindness, and it is the most common ischemic disorder of the retina. Available treatments are not very effective. Efforts to inhibit diabetic retinopathy have focused either on highly specific therapeutic approaches for pharmacologic targets or using genetic approaches to change expression of certain enzymes. However, it might be wise to choose innovative treatment modalities that act by multiple potential mechanisms. The resistance to ischemic injury, or ischemic tolerance, can be transiently induced by prior exposure to a non-injurious preconditioning stimulus. A complete functional and histologic protection against retinal ischemic damage can be achieved by previous preconditioning with non-damaging ischemia. In this review, we will discuss evidence that supports that ischemic conditioning could help avert the dreaded consequences that results from retinal diabetic damage.
糖尿病性视网膜病变是后天性失明的主要原因,也是视网膜最常见的缺血性疾病。现有的治疗方法效果不太理想。抑制糖尿病性视网膜病变的努力要么集中在针对药理学靶点的高度特异性治疗方法上,要么采用基因方法来改变某些酶的表达。然而,选择通过多种潜在机制起作用的创新治疗方式可能是明智的。对缺血性损伤的耐受性,即缺血耐受,可通过预先暴露于非损伤性预处理刺激而短暂诱导。通过先前用非损伤性缺血进行预处理,可以实现对视网膜缺血损伤的完全功能和组织学保护。在本综述中,我们将讨论支持缺血预处理有助于避免视网膜糖尿病损伤所导致的可怕后果的证据。